Geode Capital Management LLC Sells 30,408 Shares of Maximus, Inc. (NYSE:MMS)

Geode Capital Management LLC lowered its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 2.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,494,751 shares of the health services provider's stock after selling 30,408 shares during the quarter. Geode Capital Management LLC owned about 2.62% of Maximus worth $111,606,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. EP Wealth Advisors LLC acquired a new position in Maximus in the 3rd quarter valued at approximately $269,000. MML Investors Services LLC increased its position in Maximus by 6.5% in the third quarter. MML Investors Services LLC now owns 4,870 shares of the health services provider's stock worth $454,000 after purchasing an additional 299 shares during the period. Y Intercept Hong Kong Ltd bought a new stake in Maximus during the 3rd quarter worth about $1,008,000. Public Employees Retirement System of Ohio bought a new position in shares of Maximus in the 3rd quarter valued at about $159,000. Finally, Barclays PLC grew its position in shares of Maximus by 285.1% during the 3rd quarter. Barclays PLC now owns 170,971 shares of the health services provider's stock worth $15,927,000 after buying an additional 126,573 shares during the period. 97.21% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Remove Ads

Maximus Trading Down 0.7 %

Shares of NYSE MMS traded down $0.48 during midday trading on Tuesday, reaching $68.27. 30,353 shares of the stock were exchanged, compared to its average volume of 546,901. The business has a 50-day simple moving average of $67.75 and a two-hundred day simple moving average of $75.87. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company has a market capitalization of $3.86 billion, a price-to-earnings ratio of 14.68 and a beta of 0.68. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, equities research analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio is 25.81%.

Analysts Set New Price Targets

MMS has been the topic of a number of recent research reports. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.